MITO2i launched as Inistutional Strategic Initiative

Mitochondrial Innovation Initiative (MITO2i) logo

Published on Mar 25, 2020


Tags: MITO2i

What MITO2i does:


The relationship between mitochondrial dysfunction and severe mitochondrial disease has long been known. More recent research has established links to a broad range of neurodegenerative and metabolic disorders. This is a game-changer. Unveiling how mitochondrial dysfunction is implicated in multiple diseases will transform medical diagnoses, technologies and drug delivery systems, leading to a paradigm shift in the prevention and treatment of disease.

As mitochondrial research continues to accelerate, a lack of infrastructure for collaboration, knowledge integration and coordinated data-sharing prevents the development of a comprehensive, big-picture understanding of this crucial and emerging area of medicine that plays a role in many diseases and spans multiple disciplines, and areas of research. Together with its partners, the MITO2i aims to deliver supporting technologies, integrative platforms, and interdisciplinary knowledge that will lead to a paradigm shift in the way clinicians approach the diagnosis and treatment of disease and consider the potential role of mitochondrial dysfunction in multiple and prevalent medical conditions.